Seasoned healthcare operator and strategic investor with experience building growth-stage services and technology businesses for payors and providers. J. Derieck Hodges has led corporate development, M&A and commercial strategy roles, and sits on industry boards advising scaling and go-to-market execution. Market-facing skills include commercial partnerships, capital formation and operational turnarounds; engages with private equity and venture investors on health sector deals.
Seasoned healthcare operator and strategic investor with experience building growth-stage services and technology businesses for payors and providers. J. Derieck Hodges has led corporate development, M&A and commercial strategy roles, and sits on industry boards advising scaling and go-to-market execution. Market-facing skills include commercial partnerships, capital formation and operational turnarounds; engages with private equity and venture investors on health sector deals.
Operates as a growth‑oriented healthcare investor focusing on services and healthtech businesses serving payors and providers. Prefers equity and structured minority stakes to accelerate commercial scale, partnering with management on go‑to‑market, partnerships and operational turnarounds. Investment decisions hinge on measurable clinical or cost outcomes, predictable revenue models, and defensible distribution channels. Time horizon is growth-cycle oriented (3–7 years), with active portfolio governance, disciplined capital allocation, and readiness to syndicate alongside PE and venture partners to de‑risk execution.
Operates as a growth‑oriented healthcare investor focusing on services and healthtech businesses serving payors and providers. Prefers equity and structured minority stakes to accelerate commercial scale, partnering with management on go‑to‑market, partnerships and operational turnarounds. Investment decisions hinge on measurable clinical or cost outcomes, predictable revenue models, and defensible distribution channels. Time horizon is growth-cycle oriented (3–7 years), with active portfolio governance, disciplined capital allocation, and readiness to syndicate alongside PE and venture partners to de‑risk execution.
| Trades 88 | Longs Won 60/88 68% | Profit Factor 12.69 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $392,664.49 |
| Average Win $306,285.11 | Best Trade (Oct 05) $2.43M | Sharpe Ratio -749.77 |
| Average Loss -$51,735.77 | Worst Trade (Sep 10) -$504,918.36 | Z-Score 5.28 (100%) |
| Commissions $0 | Avg. Trade Length 1y 9m 1w 2d | Expectancy $192,369.38 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 1,812 | 1,630 | 1,449 | 1,268 | 1,087 | 906 | 725 | 543 | 362 | 181 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 12,961 | $3.27M | $4.27M | - | $997,678.17 | 30.52% | -1.155% |
ABBV AbbVie Inc. | 1,191 | $209,856 | $310,076.85 | - | $100,220.85 | 47.76% | -0.474% |
AEP American Electric Power Company, Inc. | 2,485 | $228,769 | $297,305.4 | - | $68,536.4 | 29.96% | +0.843% |
AMGN Amgen Inc. | 1,163 | $301,573 | $477,469.65 | - | $175,896.65 | 58.33% | -2.6% |
AMZN Amazon.com Inc | 5,268 | $1.17M | $1.31M | - | $144,077.2 | 12.36% | -0.201% |
AVGO Broadcom Inc. | 2,095 | $493,539 | $726,504.1 | - | $232,965.1 | 47.2% | -1.256% |
BINC iShares Flexible Income Active ETF | 10,391 | $540,529 | $525,420.91 | - | -$15,108.09 | -2.8% | -0.443% |
BMY Bristol-Myers Squibb Company | 4,166 | $233,547 | $255,750.74 | - | $22,203.74 | 9.51% | -1.619% |
BRK-B Berkshire Hathaway Inc. | 515 | $232,862 | $257,402.15 | - | $24,540.15 | 10.54% | +0.374% |
COST Costco Wholesale Corporation | 239 | $220,408 | $218,965.82 | - | -$1,442.18 | -0.65% | +0.641% |
CVX Chevron Corporation | 2,335 | $334,060 | $483,366.01 | - | $149,306.01 | 44.69% | +1.371% |
DUK Duke Energy Corporation | 2,338 | $251,826 | $265,713.7 | - | $13,887.7 | 5.51% | -0.316% |
DYNF iShares U.S. Equity Factor Rotation Active ETF | 38,446 | $1.98M | $2.67M | - | $692,614.23 | 34.99% | +0.354% |
EFG iShares MSCI EAFE Growth ETF | 14,052 | $1.36M | $1.67M | - | $311,125.32 | 22.82% | -0.559% |
EFV iShares MSCI EAFE Value ETF | 26,218 | $1.37M | $2.04M | - | $665,542.95 | 48.45% | -1.725% |
EMB iShares J.P. Morgan USD Emerging Markets Bond ETF | 2,423 | $216,154 | $218,748.44 | - | $2,594.44 | 1.2% | -0.616% |
EMXC iShares MSCI Emerging Markets ex China ETF | 12,586 | $698,785 | $1.25M | - | $551,508.24 | 78.92% | +0.262% |
ENBFF Enbridge Inc. Preferred Stock 2.983% Perpetual | 5,535 | $54,519.75 | $85,792.5 | - | $31,272.75 | 57.36% | 0.0 |
ETR Entergy Corporation | 3,186 | $241,349 | $319,699.17 | - | $78,350.17 | 32.46% | +1.093% |
FLBL Franklin Senior Loan ETF | 11,423 | $277,066 | $260,501.51 | - | -$16,564.49 | -5.98% | -0.848% |